CRISPR-Cas9 Screen Identifies XPO7 as a Novel Therapeutic...

Clinical Lymphoma Myeloma and Leukemia 2019 / 09 Vol. 19

CRISPR-Cas9 Screen Identifies XPO7 as a Novel Therapeutic Target for TP53-Mutated AML

Semba, Yuchiro, Yamauchi, Takuji, Nakao, Fumihiko, Nogami, Junpei, Yao, Qiuming, Canver, Matthew, Pinello, Luca, Bauer, Daniel, Akashi, Koichi, Takahiro, Maeda
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.102
Date:
September, 2019
File:
PDF, 93 KB
english, 2019
Conversion to is in progress
Conversion to is failed